DrugPatentWatch Database Preview
Chartwell Molecules Company Profile
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty approved drugs.
Summary for Chartwell Molecules
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 20 |
Drugs and US Patents for Chartwell Molecules
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecules | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077303-002 | Jun 25, 2007 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Molecules | DISULFIRAM | disulfiram | TABLET;ORAL | 091563-001 | Dec 31, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecules | ETODOLAC | etodolac | CAPSULE;ORAL | 074842-001 | Jul 17, 1997 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Molecules | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 071785-003 | Apr 5, 1988 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Molecules | NAPROXEN | naproxen | TABLET;ORAL | 074410-002 | Apr 28, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
